Downs Law Firm, P.C.

Alzheimer’s

medicaid planning

A New Alzheimer’s Medication Wins FDA Approval

Lecanemab (sold under the brand name Leqembi) helps reduce amyloid plaques in the brain, which are hallmarks of Alzheimer’s disease. Prevention’s recent article, “All About Lecanemab, the New FDA-Approved Alzheimer’s Drug,” reports that the drug was approved in January under the FDA’s Accelerated Approval pathway. This process allows the organization to approve drugs for serious…

Read More »
Search
Categories